The Amphotericin B for Injection, cataloged under National Stock Number 6505-00-962-4386, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Lyphomed Inc Div of Fujisawa Usa Inc. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 6 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-00-962-4386 |
| Primary Part Number | 23315 |
| Item Name | Amphotericin B for Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Lyphomed Inc Div of Fujisawa Usa Inc |
| Status | ACTIVE |
| Physical Form | POWDER |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 50.000 MILLIGRAMS |
| Active Medicament Medicinal Strength | 50.000 MILLIGRAMS AMPHOTERICIN B ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| 23315 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| NDC00469-2330-90 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| 43730 | Squibb E R and Sons Inc World Hq (USA) |
NSN 6505-00-962-4386 is a Amphotericin B for Injection, manufactured by Lyphomed Inc Div of Fujisawa Usa Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-00-962-4386 has 3 cross-referenced part numbers: 23315 (Lyphomed Inc Div of Fujisawa Usa Inc), NDC00469-2330-90 (Lyphomed Inc Div of Fujisawa Usa Inc), 43730 (Squibb E R and Sons Inc World Hq).
There are 6 known substitutes for 6505-00-962-4386: 5985-00-369-5409, 5140-00-498-8898, 5961-00-821-8977 and 3 more. Verify interchangeability with system specifications before substitution.
Key specifications for 23315: Physical Form: POWDER; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 50.000 MILLIGRAMS; Active Medicament Medicinal Strength: 50.000 MILLIGRAMS AMPHOTERICIN B ACTIVE INGREDIENT. 5 total characteristics are documented in the Federal Logistics Information System.